Chromosomal deletions are a common feature of epithelial tumours and when further de®ned by homozygous deletions, are often the location of tumour suppressor genes. Deletions within the short arm of chromosome 3 occur very frequently in human carcinomas: a minimal region of loss at 3p21.3 (the Luca) region has been de®ned by overlapping homozygous deletions in lung and breast cancer cell lines. Using a rapid strategy for Cre-loxP chromosome engineering, a deletion of approximately 370 kb was created in the mouse germline corresponding to the deleted region at 3p21.3. The deletion when homozygous is embryonic lethal. Heterozygotes develop normally despite being haplo-insucient for twelve genes including the candidate tumour suppressor gene Rassf1. Because damage to 3p21.3 often occurs very early in the sequence of genetic changes that lead to malignancy, particularly in lung and breast cancer, further genetic damage to these mice will provide the opportunity to model multi-step tumorigenesis of these tumours.
Introduction
Cancer is often described as a genetic disease to re¯ect the belief that its initiation and progress is driven by underlying speci®c genetic changes. Karyotype analysis of chromosomes from tumour cells began the work of cataloguing this genetic damage, identifying deletions and translocations which were speci®cally associated with dierent tumour types (Mitelman, 1991) . Oncogenes and tumour suppressor genes from translocation breakpoints and from within regions of deletion were isolated subsequently and their functions and aberrant functions contributing to the malignant phenotype, are being elucidated in vitro (Hesketh, 1997; Macleod, 2000) . However, cancer is a systemic and progressive disease and animal models are required to enable biological and dynamic aspects of tumour development to be studied. Chromosome engineering technology in the mouse has the potential to permit recapitulation of human chromosomal abnormalities even in situations where the aected gene is unknown (Zheng et al., 2000) . The chromosomal abnormalities are created in embryonic stem cells (ES cells) by gene targeting and Cre-loxP recombination and can be transmitted through the germ-line (Ramirez-Solis et al., 1995) .
We ®rst demonstrated the feasibility of this approach by using the Cre-loxP system to recapitulate in ES cells a translocation seen in Burkitt's lymphoma (Smith et al., 1995) . In view of our interest in deletions, we wanted to determine if this approach could be extended to create tumour-speci®c deletions that are a very common feature of epithelial tumours. Here we report the creation of a large deletion on a distal region of mouse chromosome 9, corresponding to a gene-rich region of very frequent allele loss at 3p21.3 in a wide range of human tumours (Kok et al., 1997) , the Luca region. The Luca region has been physically mapped, cloned, sequenced and studied in great detail by the International Lung Cancer Chromosome 3p21.3 Consortium . This region is particularly favourable to evaluate this approach as, besides showing the required synteny, homozygous deletions in breast and lung cancer have de®ned a minimal region of overlapping deletion of 120 kb (Sekido et al., 1998) . Although deletions in the mouse genome have been created randomly (Thomas et al., 1998) and targeted to speci®c loci (Justice et al., 1997) this is the ®rst report of a mouse deletion which mimics a human somatically arising tumour-associated deletion.
An isoform of the human 3p21.3 gene, RASSF1, which falls within the deletion region created in the mouse, is considered to be a candidate tumour suppressor gene (Dammann et al 2000) due to its methylation status in a wide range of tumours (Burbee et al., 2001; Byun et al., 2001; Agathanggelou et al., 2001; Dreijerink et al., 2001; Lee et al., 2001; Morrissey et al., 2001) and its ability to suppress tumorigenicity in soft agar and nude mouse assays (Dammann et al., 2000) . The mutant mice reported here will be useful in providing further functional evidence for the role of this gene and other candidates in the Luca region Kondo et al., 2001) , in tumour development. Deletion of 3p21.3 is believed to be a very early, pre-neoplastic event in the development of some cancers, notably those of breast (Maitra et al., 2001) and lung (Wistuba et al., 2000) . Further speci®c genetic damage is required to drive these tumours to full malignancy (Chung et al., 1995) . Introduction of further genetic changes in these deletion mice could be used to emulate this process and provide mouse models of tumour progression that might better re¯ect human disease.
Results
Characterisation of the mouse chromosome 9 region syntenic to 3p21.3
In order for the mouse mutants to eectively model the human deletion(s), the mouse syntenic region to be targeted for deletion must ideally be identical in gene content and order to the equivalent human Luca region. At the beginning of this work, detailed information on the mouse sequence was not available, although comparison of gene synteny maps indicated that the deleted Luca genes were clustered on mouse chromosome 9. To make a deletion¯anking the minimal human deletion of 120 kb we proposed to delete from Hyal1 to 3pk ( Figure 1A ). Using FISH, we con®rmed that our chosen¯anking markers were adjacent on chromosome 9, ®rst by hybridizing them independently to normal mouse metaphase chromosomes and showing that both genes are located at the distal end of chromosome 9 (Figure 2A ,B) and then by hybridizing them simultaneously using dual colour FISH, which showed their immediate proximity to each other ( Figure 2C ). Following generation of the mutant mice described below, a partially sequenced mouse BAC (RP23-93E) became available, which allowed comparison of the human and mouse Luca region. Where comparison was possible, the human and mouse gene content was the same in the Luca region (Figure 1 ).
Generation of mice with germline transmission of the 3pk-Hyal1 deletion
The strategy for construction of the mouse deletion is shown in Figure 3 . This involved sequential rounds of transfection and clone selection in ES cells ®rst to de®ne the deletion end points by targeted integration of loxP sites, and then to create the deletion between these by Cre-mediated recombination. Cre-mediated recombination results in concomitant reconstruction of a functional hypoxanthine phosphoribosyl transferase (Hprt) mini-gene from a pair of defective gene and Hprt 7D5' ) joined to the targeted loxP sites, thus providing a genetic selection for chromosomal rearrangement in HPRT de®cient cells (HPRT 7 ) (Smith et al., 1995) . The consensus minimal human deletion at 3p21.3 spans 120 kb from CACNA2D2 to HYAL1. However, it was not possible to exactly recapitulate this deletion in mouse due to lack of sequence information at the inception of vector construction. This necessitated extension beyond the proximal boundary of the human minimal deletion from Cacna2d2 to 3pk. The relative orientations of loxP sites at the desired end points on the chromosome determine the nature of the chromosomal rearrangements (deletion, duplication, inversion). Although the relative orientations of the human 3PK and HYAL1 genes were known on chromosome 3, no de®nitive information was available concerning relative chromosomal order and orientation of the murine genes. In order to guarantee generation and selection of this deletion, it was therefore necessary to construct targeting vectors for the 3pk and Hyal1 loci with cassettes containing Hprt 7D3' /loxP and loxP/Hprt 7D5' cassette at a position in the 5' noncoding region of the gene, were separately transfected into these two 3pk targeted cell lines. These transfections involved co-electroporation with the Cre expression plasmid pCAGGS-Cre-IRESpuro. In this experimental strategy Cre-mediated recombination can in principle occur simultaneously with or immediately after targeted integration. Thus cells can be selected directly for chromosomal rearrangements in HAT medium from this second round of transfection obviating the need to select and screen ®rst for targeted integration into the Hyal1 locus. Colonies were recovered after HAT selection from all four possible combinations of 3pk targeted cell line and Hyal1 targeting vector type at frequencies in the range of 10 75 to 10 76 . Figure 3 illustrates the required chromosomal orientations of the cassettes successively targeted into the 3pk and Hyal1 loci (in the potential situation in which these loci are centromere proximal and centromere distal respectively) for selection of the deletion. A consequence of the deletion is the predicted loss of both the MC1neopA and PGKhygpA selection markers which are excised from the chromosome with the intervening deletion region, whereas for other classes of rearrangement (inversion and duplication) these should be retained. Screening HAT R clones derived from each of the four second round transfections for resistance/sensitivity to G418 and hygromycin can therefore be used as a strong indicator of which contained the deletion event. The majority of HAT R clones from one of the second round transfections were sensitive to both G418 and hygromycin, whereas from the other three transfections the majority of HAT R clones were resistant to both drug selections. The G418 and hygromycin sensitive class of HAT R clones were derived from the combination of the Hprt 7D3' /loxP/ MC1neopA cassette inserted in the opposite orientation relative to the 3pk gene and the PGKhygpA/loxP/ Hprt 7D5' cassette inserted in the same orientation relative to the Hyal1 gene. The implication of this is that the 3pk and Hyal1 genes are in opposite and divergent transcriptional orientations on chromosome 9, which in fact is the same as their human orthologues on 3p. This arrangement is shown in Figure 4 together with the data from subsequent Southern blot analysis of this class of HAT R clones. This con®rmed the following: reconstruction of the Hprt mini-gene, the absence of neo and hyg selection marker sequences, the joining via the Hprt gene of 3pk sequences from the 3' side of the original Hprt 7D3' /loxP/MC1neopA cassette insertion position to Hyal1 sequences from the 3' side of the original PGKhygpAloxP/Hprt 7D5' cassette insertion position, and the loss of intervening 3pk and Hyal1 sequences.
To visualise the dierence between the normal and rearranged chromosome 9 in the HAT R ES cells described above and to support the evidence from Southern blotting, a probe (p401-R6.5), corresponding to a sequence within the targeted deletion interval, was hybridized to metaphase spreads of cells from one of the HAT R clones and control ES cells. The probe hybridized to both copies of chromosome 9 in the control ES cells but to only one copy of chromosome 9 in the transfected cells indicating that the 3pk-Hyal1 region was deleted from the unlabelled homologue ( Figure 5A,B) . The karyotype of the ES cells carrying the 3pk-Hyal1 deletion appeared normal otherwise, indicating that the rounds of transfection and selection had resulted in no visible cytogenetic changes.
Characterisation of the phenotype and genotype of mutant mice
Two deletion clones (DEL-3 and DEL-4) were injected into C57BL/6 blastocysts and following breeding of chimeras, germline transmission was determined by Diagram of the vector and chromosomal sequences before and after homologous recombination and site-speci®c recombination events that generate the chromosomal deletion showing the diagnostic restriction fragments and probes used to detect these sequences. Thick black lines represent chromosomal sequence and cloned genomic DNA sequence in the vectors; relevant exons are represented by un®lled boxes; thick dashed lines,¯anked by angled parallel pairs of bars, represent discontinuous sequence corresponding to the intervening chromosomal region between 3pk and Hyal1. The Hprt, MC1neoPA and PGKhygpA selection marker sequences, and the loxP site, are indicated as described in the legend to Figure 3 ; the MC1tk dimer cassette present in both targeting vectors is shown by a chequered box with its pointed end denoting orientation as in the convention used in Figure 3 ; and pBluescript plasmid sequence in both vectors by a thin black line. Double cross-over homologous recombination events and Cre-mediated recombination are indicated by thin dashed lines. BglII and EcoRI restriction endonuclease sites are shown by small arrows labelled Bg and E respectively and relevant enzyme fragments with a dotted line with size in kilobases. A dotted line also denotes the intervening chromosomal region between targeted loci with the approximate size based on the equivalent human sequence. Sequences used for hybridization probes are shown by small bars above and in parallel with the chromosomal sequence and are labelled a, b, c, or d. The relative orientation of the 3pk and Hyal1 loci indicated by arrow heads in the un®lled boxes is inferred from the particular combination of 3pk and Hyal1 targeting vector types (i.e. orientation of cassette with respect to coding sequence) that gives rise to the deletion. Southern blot analysis (result not shown). Mice heterozygous for the deletion develop, mature and breed normally on two dierent genetic backgrounds (Table 1) . Inter-breeding heterozygous mice generates embryos homozygous for the 3pk-Hyal1 deletion which appear at day 9.5 to be signi®cantly smaller and developmentally retarded compared to wild type and heterozygous embryos. Homozygous embryos probably start dying by day 11.5 and none persist beyond day 13.5. Fixation and sectioning of the embryos revealed incomplete development of the tail and forebrain. In some embryos there was obvious oedema of the heart and abnormal vascularization (results not shown). Isolation of DNA from homozygous deletion embryos allowed con®rmation by PCR analysis that the following genes, predicted from the human sequence to lie within the deletion interval (see Figure 1 ), were absent: Hyal2, Rassf1, Blu, G21, Loc56368, PI6, Cacna2d2, Henk and Cish (no mouse sequence is available to construct primers to test G20) (Figure 6 ). The primers for the Fus1 gene ampli®ed a PCR product from the homozygous embryo DNA. The sequence of this PCR product was identical to neither the Fus1 gene on chromosome 9 (accession no. NM 019742) nor to the Fus1 sequence in the BAC which suggests that it derives from a related but unlinked locus. Thus this analysis suggests that gene content is conserved between human and mouse Luca regions. Additionally it con®rms that the sequence excised following Cre-mediated loxP recombination was lost from the genome and had not been re-integrated elsewhere. By comparing the DNA from the homozygous deletion embryos with normal mouse embryo DNA at loci¯anking the predicted deletion breakpoints (3pk, Hyal1 and Fus2), it was possible to con®rm that the breakpoints were as expected from the design of the chromosome engineering strategy (Figure 6 ).
Discussion
Cre-loxP chromosome engineering in mouse ES cells is a powerful technology with a range and eciency analysis of the products of homologous and Cre-loxP-mediated recombination at the mouse 3pk-Hyal1 locus. Genomic DNA prepared from: lane 1, the original ES cell line (E14-TG2a); lane 2 ES cell clone targeted at the 3pk locus obtained with the vector shown above; lane 3, HAT R cell clone obtained after co-transfection with the Hyal1 vector shown above and the pCAGGS-CreIRESpuro expression vector. DNAs were digested with BglII (F, G, and H) and EcoRI (I). These data are from ospring derived from the fourth generation of back-crossing the 3pk-Hyal1 deletion onto the C57BL/6 strain subsequent to test-crossing chimeras with C57BL/6. b These data are from ospring derived from maintaining the 3pk-Hyal1 deletion on a pure 129/Ola strain by backcrossing for two generations subsequent to test-crossing of chimeras with 129/Ola allowing virtually any chromosomal rearrangement to be created compatible with cell viability (Zheng et al., 2000) . It therefore has considerable potential for modelling in mice, human chromosomal deletions associated with congenital defects, or somatically acquired as in cancer. Once a region of synteny in the mouse corresponding to the human deletion region can be identi®ed and shown to contain similar gene content, the technology can be applied with few constraints. Indeed, as exempli®ed in this report, genome sequence information to de®ne relative orientations of prospective deletion end points is not really a requirement to initiate chromosome engineering. By implementing the second gene targeting step and Cre/loxP recombination step simultaneously, ES cell lines that had undergone chromosomal rearrangements from all possible orientations of loxP sites were rapidly generated; subsequent scoring of drug resistance/sensitivity phenotypes identi®ed the class of recombinant clones likely to contain the desired deletion and so also implied the relative orientations of the end point sequences. Creating deletions by simultaneous transfection of the vector carrying the second loxP site and a Cre recombinase expression plasmid is therefore an eective variation on the conventional strategy, which, as has also been reported by others (LePage et al., 2000; Li et al., 1996) is applicable to many chromosome engineering projects in ES cells. It has an important advantage that by reducing the number of transfection steps, it further minimizes the chance of compromising germ line transmission potential of the manipulated ES cells.
Using this approach we have generated viable mice with germ-line transmission of a heterozygous deletion of around 370 kb rendering at least 12 genes haploid. No abnormal phenotypes have been detected in these mice up to an age of eight months, enabling the development of cohorts for further experimentation. We envisage three main ways in which these mutant mice could be utilized. The ®rst approach would use mutagenesis to reveal whether recessive mutations within the region of segmental haploidy could contribute to tumour development (Justice et al., 1997) . If genetic damage to the remaining Rassf1 allele correlates with a tumour phenotype this will provide direct functional evidence for the role of this gene in tumour formation. Secondly, to dissect out the function of the genes in the deletion interval, the embryonic lethal phenotype could be rescued by transgenesis of BAC or PAC clones carrying one or more genes from the deleted region (Zhu et al., 2000) . Viable mice may then develop phenotypes due to the homozygous loss of uncomplemented genes: these phenotypes would indicate which gene or genes may be related to tumour development. This strategy will be particularly valuable if, as seems likely Kondo et al., 2001) , several genes within this deletion interval contribute to the tumour phenotype. Thirdly, the Luca deletion mice could be bred with mice carrying mutations known to be involved in early stages of tumour progression to develop animal models of early tumour growth. Human epithelial tumours often develop via preinvasive lesions of increasing morphological abnormality driven by accumulation of locus-speci®c somatic genetic changes (Vogelstein and Kinzler, 1993) . Since damage to the 3p21.3 locus is such an early event in human tumorigenesis, this approach may produce preinvasive phenotypes in tumour development that resemble human pre-neoplastic lesions. The ability to mimic these in the mouse would provide a model for the investigation of early therapeutic interventions. Such trials are dicult in humans because of lack of intermediate end points making the studies extremely protracted and the ethical considerations relating to the treatment of individuals who are overtly free of disease. The generation of these Luca deletion mice therefore completes the ®rst phase of realising this goal.
Materials and methods

Chromosome engineering
Targeting vectors designed to deliver the chromosome engineering cassettes for the 3pk and Hyal1 loci were constructed from 129/Ola genomic DNA. The chromosome engineering cassettes, contained as BamHI restriction fragments, each comprised: a selection marker conferring resistance to G418 or hygromycin (MC1neopA or PGKhygpA); a loxP sequence; and one of two dierent defective but complementary segments of human Hprt mini-gene sequence (Hprt 7D3' and Hprt 7D5' ) to enable selection for Cre-mediated recombination events. These were modi®ed versions of the cassettes previously described (Smith et al., 1995) incorporating additional sequences to facilitate multiple and complex genome engineering manipulations (K Johnstone et al., in preparation). The vectors were replacement vectors designed for positive-negative selection of targeted cells (Mansour et al., 1988) and contained an HSV thymidine kinase gene sequence (an MC1tk dimer cassette) on the end of one of the homology arms (Smith et al., 1995) .
Seventy-®ve mg of each version of the 3pk targeting vector linearized with SalI was electroporated into 5610 7 E14-TG2a.IV cells (derived from the 129/Ola strain) as previously Figure 6 PCR analysis of genes within and¯anking the 3pk-Hyal1 region. For each locus, DNA from homozygous deletion (7/7) and wild type embryos (+/+) was ampli®ed in parallel with a no DNA negative control (c). The loci were 3pk(10) [exon 10 of the 3pk gene], 3pk(2) [exon 2 of the 3pk gene], Cish, Hemk, Cacna2d2, PI6, Loc56368 (known as 101F6 in human), G21 (known as NPRL2 in human), Blu (known as BLU2 in human), Rassf1, Fus1, Hyal1 and Hyal2. 3pk (10), the coding region of the Hyal1 gene and Fus2¯ank the deletion and are ampli®ed from both 7/7 and +/+ DNA described (Smith et al., 1995) and cells selected in G418 and ganciclovir. Targeted clones were identi®ed by Southern blotting of BglII digested DNA and hybridization with 3pk probes corresponding to sequence external to and¯anking the region encompassed by the vector homology arms.
The second targeting vector to de®ne the other prospective end point for chromosomal rearrangement was constructed to insert the PGKhygpA/loxP/Hprt 7D5' cassette into the Hyal1 locus. In separate transfections 75 mg of each version of the Hyal1 targeting vector linearized with NotI was coelectroporated with 50 mg of the Cre expression vector pCAGGS-Cre-IRESpuro (K Johnstone et al., in preparation) into 5610 7 cells of the 3pk targeted cell lines derived from the ®rst round of transfections. Cells were selected 24 h later in medium supplemented with hypoxanthine, aminopterin and thymidine (HAT selection). After 10 days, colonies resistant to HAT selection (HAT R ) were picked into 96-well plates, grown for 3 ± 4 days and then multiple replica plates made for freezing, genomic DNA preparation and to test resistance or sensitivity to G418 and hygromycin. Southern blot analysis of genomic DNA from these HAT R clones digested with BglII, BamHI and EcoRI was carried out using hybridization probes speci®c to the cassette sequences and to sequences¯anking the 3pk and Hyal1 sequence contained in the targeting vectors.
Fluorescent in situ hybridization (FISH)
Plasmids corresponding to the 3pk and Hyal1 genes as described above were puri®ed and labelled using¯uorescent nucleotides. Chromosome spreads from mouse spleen cells or ES cells were prepared as described (Smith et al., 1995) with minor modi®cations to the cell swelling and ®xation steps. Fluorescent in situ hybridization was performed according to the manufacturer's instructions (Cambio). A Digital Scienti®c uorescence workstation was used for visualization.
Chimera generation and mouse breeding
ES cell clones with the desired chromosomal deletion were injected into C57BL/6 blastocysts to generate chimeric mice.
Male chimeras were test-crossed with C57BL/6 females and agouti ospring genotyped by tail biopsy and Southern blotting with 3pk and Hyal1 gene speci®c probe fragments to identify deletion heterozygotes. The deletion strains were maintained by back-crossing of male carriers at each generation with C57BL/6 females. High transmitting chimeras were also test-crossed to 129/Ola female mice to obtain the deletion mutation on a pure genetic background; this strain was also maintained by back-crossing of male carriers at each generation with 129/Ola females.
Genotyping and PCR analysis of time-mated embryos
Total genomic DNA was extracted by conventional methods from amniotic sacs of day 8.5 to 12.5 embryos following timed mating of heterozygotes and genotypes determined as above. Genomic DNA from wild type embryos (+/+) and homozygous deletion embryos (7/7) was analysed by PCR using primer pairs corresponding to coding exons of genes within the deletion chosen from gene sequences provided by GenBank. Primer concentration was 0.2 mM and MgCl 2 1.5 mM. Ampli®cation conditions were 958C denaturing step for 12 min followed by 30 cycles of 958C for 50 s, 568C for 50 s, 728C for 50 s and a ®nal extension of 10 min at 728C. The products of the PCR were separated on 2% agarose gels and were identi®ed by staining with ethidium bromide. The primer pairs each produced a single band from total mouse genomic DNA.
